×
Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.
TNFRSF10B Antikörper (APC)
TNFRSF10B
Reaktivität: Human
FACS, ICFC
Wirt: Maus
Monoclonal
DJR2-4 (7-8)
APC
Produktnummer ABIN2658556
Produktdetails anti-TNFRSF10B Antikörper (APC)
(ausblenden)
Target
Alle TNFRSF10B Antikörper anzeigen
TNFRSF10B
(Tumor Necrosis Factor Receptor Superfamily, Member 10b (TNFRSF10B))
Reaktivität
Alle Reaktivitäten für TNFRSF10B Antikörper
Human
Wirt
Alle Wirte für TNFRSF10B Antikörper
Maus
Klonalität
Alle Klonalitäten für TNFRSF10B Antikörper
Monoklonal
Konjugat
Alle Konjugate für TNFRSF10B Antikörper
Dieser TNFRSF10B Antikörper ist konjugiert mit APC
Applikation
Alle Applikationen für TNFRSF10B Antikörper
Flow Cytometry (FACS), Intracellular Flow Cytometry (ICFC)
Aufreinigung
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions. The solution is free of unconjugated APC and unconjugated antibody.
Klon
DJR2-4 (7-8)
Isotyp
IgG1 kappa
Top Product
Discover our top product TNFRSF10B Primärantikörper
Alternativen
(anzeigen)
Anwendungsinformationen
(ausblenden)
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Handhabung
(ausblenden)
Buffer
Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide and 0.2 % (w/v) BSA .
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung
Protect from prolonged exposure to light. Do not freeze.
Lagerung
4 °C
Informationen zur Lagerung
The antibody solution should be stored undiluted between 2°C and 8°C.
Details zu TNFRSF10B
(ausblenden)
Target
TNFRSF10B
(Tumor Necrosis Factor Receptor Superfamily, Member 10b (TNFRSF10B))
Andere Bezeichnung
CD262 (TNFRSF10B Produkte )
Synonyme
TNFRSF10B antikoerper, dr5 antikoerper, cd262 antikoerper, killer antikoerper, trick2 antikoerper, trickb antikoerper, xDR-M1 antikoerper, xDR-M2 antikoerper, ztnfr9 antikoerper, trailr2 antikoerper, trick2a antikoerper, trick2b antikoerper, CD262 antikoerper, DR5 antikoerper, KILLER antikoerper, KILLER/DR5 antikoerper, TRAIL-R2 antikoerper, TRAILR2 antikoerper, TRICK2 antikoerper, TRICK2A antikoerper, TRICK2B antikoerper, TRICKB antikoerper, ZTNFR9 antikoerper, Ly98 antikoerper, MK antikoerper, tumor necrosis factor receptor superfamily, member 10b antikoerper, tumor necrosis factor receptor superfamily member 10b S homeolog antikoerper, tumor necrosis factor receptor superfamily member 10b L homeolog antikoerper, tumor necrosis factor receptor superfamily member 10b antikoerper, TNF receptor superfamily member 10b antikoerper, Tnfrsf10b antikoerper, TNFRSF10B antikoerper, tnfrsf10b.S antikoerper, tnfrsf10b.L antikoerper, tnfrsf10b antikoerper
Hintergrund
DR5 is 55 kD member 10B of the TNF receptor superfamily (TNFRSF10B), also known as TRAIL-R2, TRICK2, KILLER, and CD262. It binds the cytotoxic ligand TRAIL and induces apoptosis. The DR5 receptor is broadly expressed on a variety of normal tissues and many tumors. DR5 expression has been reported to be upregulated in human cells by interferon-α, 2-methoxyestradiol, and paclitaxel, and downregulated by adenoviral E3 proteins.
Pathways
p53 Signalweg , Apoptose , Positive Regulation of Endopeptidase Activity
Zuletzt angesehen
(ausblenden)